http://www.biodefensestudy.org/defense-of-animal-agriculture

Dr. Kimothy Smith, DVM, Chief Science Officer of ExcitePCR, white paper co-author, and former Senior Advisor for International Biodefense for the Department of Homeland Security, Office of Health Affairs called in to SmallCapVoice.com to go over the markets, applications and growing need around the world for the FireflyDX family of products. ExcitePCR Corporation is a subsidiary of PositiveID Corporation (OTC PSID), a life sciences company focused on detection and diagnostics. In the interview, Dr. Smith touches on the the Blue Ribbon Study Panel report on biodefense, specifically the report titled Defense of Animal Agriculture that evaluates threats to animal agriculture, which is central to the health and well-being of the population and the security of one of the largest sectors of the U.S. economy http://www.biodefensestudy.org/defense-of-animal-agriculture. The global food safety testing market, which according to a report by Global Industry Analysts is projected to reach $19.7 billion by 2018, driven by the continuous rise in the product recalls due to contamination by bacteria and other microorganisms, rising awareness about the harmful effects of consuming contaminated food, and implementation of stringent regulatory specifications. the FireflyDX products addressing some of the issues in the Blue Ribbon report.

PositiveID Corporation is a life sciences tools and diagnostics company with an extensive patent portfolio. PositiveID develops biological detection and diagnostics systems, specializing in the development of microfluidic systems for the automated preparation of and performance of biological assays. PositiveID is also a leader in the mobile technology vehicle market, with a focus on the laboratory market and homeland security. For more information on PositiveID, please visit http://www.psidcorp.com

This interview may include forward looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this release. Although the Company believes that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof.